Delivery Order SPE2DR25D1002-SPE2DR26FGL7G
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Latuda 80 mg tablets (30-count units) with a ceiling value of $5,922.45. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Latuda 20 mg tablets (30-count) valued at $4,191.82 under a firm fixed-price contract. The award was made on May 14, 2025, with an ultimate completion date of May 15, 2025, and the product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Latuda 120 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $9,820.56. The order is scheduled for completion by November 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's proven...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count) on September 25, 2025, with a ceiling value of $19,403.50. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,295.43 to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Latuda 60 mg tablets in quantities of 30 units, with a contract ceiling value of $3,132.62. This firm fixed-price delivery order is non-competitive and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The contract is scheduled for completion by April 22, 2025, and will be fulfilled from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $6,606.26. The award, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGL7GDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 60 mg tablets (30-count units) with a ceiling value of $4,235.43. This is a firm fixed price delivery order with no set-aside designation, issued competitively on December 19, 2025, with an ultimate completion date of December 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Latuda is an atypical antipsychotic medication used in military and veteran healthcare systems, and this order represents one of numerous delivery orders placed against the company's expansive pharmaceutical supply agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 12/18/25 |